North America Clinical Trial Imaging Market Forecast to 2028 -Regional Analysis - by Modality, Offering (Operational Imaging Services, Imaging Software, Read Analysis Services, Trial Design and Consulting Services, and Others), and End User

List of Tables

The North America clinical trial imaging market is expected to grow from US$ 704.94 million in 2023 to US$ 1,025.61 million by 2028; it is estimated to register a CAGR of 7.8% from 2023 to 2028.

Spur in Number of CROs Offering Medical Imaging Services Fuels North America Clinical Trial Imaging Market

Clinical research organizations (CROs) assist in the successful implementation of clinical trials through the services offered using high-quality facilities and deep subject matter expertise. CROs have begun acting as a backbone of the clinical trial industry through their efficient and cost-effective operations that benefit trial sponsors. For example, on average, CROs take 30% lesser time than in-house activity to conduct and complete clinical trials. With the rising number of CROs leading to high competition, a few of these businesses offer specialized imaging services, thus emerging as imaging CROs (iCROs). A few examples of iCROs include Keosys Medical Imaging and Medica Group PLC. CROs offer key knowledge insights in areas such as site qualification for imaging, acquisition of standardized images, and determination of read designs and criteria, thereby contributing to the growth of the overall North America clinical trial imaging market.

North America Clinical Trial Imaging Market Overview

The North America clinical trial imaging market is segmented into the US, Canada, and Mexico. The US is the largest and fastest-growing market for clinical trial imaging. The market growth in the region is attributed to the US emerging as a leading clinical research destination and a growing number of innovative product launches by companies for applications in clinical trials. The US has emerged as a leading clinical research destination. Approximately half of the total clinical trials conducted globally are conducted in the US. Additionally, most pharma research companies prefer to perform clinical trials in the US owing to established medical infrastructure, fast approval timelines, a favorable regulatory framework, and accepted clinical trial-generated data.

North America Clinical Trial Imaging Market Revenue and Forecast to 2028 (US$ Million)

North America Clinical Trial Imaging Market Segmentation

The North America clinical trial imaging market is segmented on the basis of modality, offering, end user, and country.

Based on modality, the North America clinical trial imaging market is segmented into tomography, magnetic resonance imaging (MRI), ultrasound, positron emission tomography (PET), X-ray, echocardiography, and others. The tomography segment registered the largest market share in 2023.

Based on offering, the North America clinical trial imaging market is segmented into operational imaging services, imaging software, read analysis services, trial design and consulting services, and others. The operational imaging services segment held the largest market share in 2023.

Based on end user, the North America clinical trial imaging market is segmented into contract research organizations (CROs), pharmaceutical and biotechnology companies, academic and research institutes, and others. The contract research organizations (CROs) segment held the largest market share in 2023.

Based on country, the market is segmented into US, Canada, and Mexico. The US dominated the market share in 2023.

BioTelemetry Inc, Calyx Inc, eResearch Technology Inc, ICON PLC, IXICO plc, Medical Metrics Inc, Medpace Holdings Inc, VIDA Diagnostics Inc, and WCG Clinical Inc are the leading companies operating in the North America clinical trial imaging market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America clinical trial imaging market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the North America clinical trial imaging market, thereby allowing players across the value chain to develop effective long-term strategies
develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the clinical trial imaging market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Product Code: BMIRE00028633

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 North America Market Segmentation
- 1.3.1 North America Clinical Trial Imaging Market - by Modality
- 1.3.2 North America Clinical Trial Imaging Market - by Offering
- 1.3.3 North America Clinical Trial Imaging Market - by End User
- 1.3.4 North America Clinical Trial Imaging Market - by Country

2. North America Clinical Trial Imaging Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Clinical Trial Imaging Market - Market Landscape

4.1 Overview
- 4.1.1 North America PEST Analysis
4.2 Expert Opinion

5. North America Clinical Trial Imaging Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Accelerated Clinical Trial Activities in Pharmaceutical and Biotechnology Industry
- 5.1.2 Spur in Number of CROs Offering Medical Imaging Services
5.2 Market Restraints
- 5.2.1 High Investment and Standardized Infrastructure Requirements
5.3 Market Opportunities
- 5.3.1 In-Silico Imaging Clinical Trials
5.4 Future Trends
- 5.4.1 AI-Driven Clinical Trials
5.5 Impact Analysis

6. North America Clinical Trial Imaging Market

6.1 North America Clinical Trial Imaging Market Revenue Forecast and Analysis

7. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - by Modality

7.1 Overview
7.2 North America Clinical Trial Imaging Market Revenue Share, by Modality (2022 and 2028)
7.3 Tomography
- 7.3.1 Overview
- 7.3.2 Tomography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Ultrasound
- 7.4.1 Overview
- 7.4.2 Ultrasound: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Positron Emission Tomography
- 7.5.1 Overview
- 7.5.2 PET: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.6 X-Ray
- 7.6.1 Overview
- 7.6.2 X-Ray: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Echocardiography
- 7.7.1 Overview
- 7.7.2 Echocardiography: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Magnetic Resonance Imaging
- 7.8.1 Overview
- 7.8.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

8. North America Clinical Trial Imaging Market Revenue and Forecast To 2028 - Offering

8.1 Overview
8.2 North America Clinical Trial Imaging Market Revenue Share, by Offering (2022 and 2028)
8.3 Trial Design Consulting Services
- 8.3.1 Overview
- 8.3.2 Trial Design Consulting Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Read Analysis Services
- 8.4.1 Overview
- 8.4.2 Read Analysis Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Operational Imaging Services
- 8.5.1 Overview
- 8.5.2 Operational Imaging Services: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Imaging Software
- 8.6.1 Overview
- 8.6.2 Imaging Software: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

9. North America Clinical Trial Imaging Market Revenue and Forecasts To 2028- by End User

9.1 Overview
9.2 Pharmaceutical and Biopharmaceutical Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biopharmaceutical Companies: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.3 Contract Research Organizations
- 9.3.1 Overview
- 9.3.2 Contract Research Organizations: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Academic and Research Institutes
- 9.4.1 Overview
- 9.4.2 Academic and Research Institutes: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Others
- 9.5.1 Overview
- 9.5.2 Others: North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)

10. North America Clinical Trial Imaging Market - Revenue and Forecast to 2028 - Country Analysis

10.1 Overview
- 10.1.1 North America: Clinical Trial Imaging Market, by Country, 2022& 2028 (%)
  - 10.1.1.1 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 US: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.1.3 US: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.1.4 US: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.1.5 US: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Canada: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.2.3 Canada: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.2.4 Canada: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.2.5 Canada: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)
  - 10.1.1.3 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 Mexico: Clinical Trial Imaging Market - Revenue and Forecast to 2028 (US$ Million)
    - 10.1.1.3.3 Mexico: Clinical Trial Imaging Market, by Modality, 2020-2028 (US$ Million)
    - 10.1.1.3.4 Mexico: Clinical Trial Imaging Market, by Offering, 2020-2028 (US$ Million)
    - 10.1.1.3.5 Mexico: Clinical Trial Imaging Market, by End User, 2020-2028 (US$ Million)

11. Clinical Trial Imaging Market - Industry Landscape

11.1 Overview
11.2 Inorganic Growth Strategies
- 11.2.1 Overview
11.3 Organic Growth Strategies
- 11.3.1 Overview

12. Company Profiles

12.1 eResearch Technology Inc
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Calyx Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 ICON PLC
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 VIDA Diagnostics Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WCG Clinical Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 BioTelemetry Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Medical Metrics Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Medpace Holdings Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 IXICO plc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Glossary of Terms